Elbit Imaging

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Elbit Imaging and buy or sell other stocks, ETFs, and their options commission-free!

About EMITF

Elbit Imaging Ltd. operates as an investment holding company, with interests in the real estate sector in India and in the medical instruments sector in Israel. It operates through Life Sciences, and Medical Equipment segments. 

CEO
Ron Hadassi
CEORon Hadassi
Employees
20
Employees20
Headquarters
Petach Tikva, HaMerkaz
HeadquartersPetach Tikva, HaMerkaz
Founded
1996
Founded1996
Employees
20
Employees20

EMITF Key Statistics

Market cap
28.23M
Market cap28.23M
Price-Earnings ratio
-12.03
Price-Earnings ratio-12.03
Dividend yield
Dividend yield
Average volume
0.40
Average volume0.40
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$2.15
52 Week high$2.15
52 Week low
$0.051
52 Week low$0.051

Stock Snapshot

As of today, Elbit Imaging(EMITF) shares are valued at $1.80. The company's market cap stands at 28.23M, with a P/E ratio of -12.03.

During the trading day, Elbit Imaging(EMITF) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Elbit Imaging(EMITF) stock has reached 0, versus its average volume of 0.4.

The stock's 52-week range extends from a low of $0.05 to a high of $2.15.

The stock's 52-week range extends from a low of $0.05 to a high of $2.15.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.